195 related articles for article (PubMed ID: 12527186)
21. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
Zecevic DE; Meier R; Daniels R; Wagner KG
Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
[TBL] [Abstract][Full Text] [Related]
22. Influence of manufacturing factors on physical stability and solubility of solid dispersions containing a low glass transition temperature drug.
Sakurai A; Sako K; Maitani Y
Chem Pharm Bull (Tokyo); 2012; 60(11):1366-71. PubMed ID: 23124559
[TBL] [Abstract][Full Text] [Related]
23. Miscibility of Itraconazole-Hydroxypropyl Methylcellulose Blends: Insights with High Resolution Analytical Methodologies.
Purohit HS; Taylor LS
Mol Pharm; 2015 Dec; 12(12):4542-53. PubMed ID: 26567698
[TBL] [Abstract][Full Text] [Related]
24. Carbamazepine/betaCD/HPMC solid dispersions. I. Influence of the spray-drying process and betaCD/HPMC on the drug dissolution profile.
Koester LS; Mayorga P; Bassani VL
Drug Dev Ind Pharm; 2003 Feb; 29(2):139-44. PubMed ID: 12648010
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
26. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
Nunes PD; Pinto JF; Henriques J; Paiva AM
Mol Pharm; 2022 Jan; 19(1):51-66. PubMed ID: 34919407
[TBL] [Abstract][Full Text] [Related]
27. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
28. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
[TBL] [Abstract][Full Text] [Related]
29. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.
Sarabu S; Kallakunta VR; Bandari S; Batra A; Bi V; Durig T; Zhang F; Repka MA
Carbohydr Polym; 2020 Apr; 233():115828. PubMed ID: 32059882
[TBL] [Abstract][Full Text] [Related]
30. Dissolution and precipitation behavior of amorphous solid dispersions.
Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
[TBL] [Abstract][Full Text] [Related]
31. Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development.
Ousset A; Bassand C; Chavez PF; Meeus J; Robin F; Schubert MA; Somville P; Dodou K
Pharm Dev Technol; 2019 Jun; 24(5):560-574. PubMed ID: 30303440
[TBL] [Abstract][Full Text] [Related]
32. Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.
Piccinni P; Tian Y; McNaughton A; Fraser J; Brown S; Jones DS; Li S; Andrews GP
J Pharm Pharmacol; 2016 May; 68(5):705-20. PubMed ID: 26864155
[TBL] [Abstract][Full Text] [Related]
33. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
34. Physical stability of ternary solid dispersions of itraconazole in polyethyleneglycol 6000/hydroxypropylmethylcellulose 2910 E5 blends.
Janssens S; Roberts C; Smith EF; Van den Mooter G
Int J Pharm; 2008 May; 355(1-2):100-7. PubMed ID: 18191508
[TBL] [Abstract][Full Text] [Related]
35. Application of HPMC HME polymer as hot melt extrusion carrier in carbamazepine solid dispersion.
Wu H; Liu Y; Ci T; Ke X
Drug Dev Ind Pharm; 2020 Dec; 46(12):1911-1918. PubMed ID: 32942902
[TBL] [Abstract][Full Text] [Related]
36. Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.
Wlodarski K; Zhang F; Liu T; Sawicki W; Kipping T
Pharm Res; 2018 Jan; 35(1):16. PubMed ID: 29305665
[TBL] [Abstract][Full Text] [Related]
37. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
[TBL] [Abstract][Full Text] [Related]
38. Predicting physical stability of ternary amorphous solid dispersions using specific mechanical energy in a hot melt extrusion process.
Hanada M; Jermain SV; Lu X; Su Y; Williams RO
Int J Pharm; 2018 Sep; 548(1):571-585. PubMed ID: 30006310
[TBL] [Abstract][Full Text] [Related]
39. Using Supercritical Fluid Technology (SFT) in Preparation of Tacrolimus Solid Dispersions.
Obaidat RM; Tashtoush BM; Awad AA; Al Bustami RT
AAPS PharmSciTech; 2017 Feb; 18(2):481-493. PubMed ID: 27116202
[TBL] [Abstract][Full Text] [Related]
40. Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion.
Zheng X; Yang R; Tang X; Zheng L
Drug Dev Ind Pharm; 2007 Jul; 33(7):791-802. PubMed ID: 17654028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
